RITONAVIR-BASED ANTI-RETROVIRAL THERAPY IS ASSOCIATED WITH A LOWER EJECTION FRACTION AND AN INCREASED RISK FOR DECOMPENSATED HEART FAILURE AND CARDIOVASCULAR MORTALITY AMONG PERSONS LIVING WITH HIV.
Saved in:
| Title: | RITONAVIR-BASED ANTI-RETROVIRAL THERAPY IS ASSOCIATED WITH A LOWER EJECTION FRACTION AND AN INCREASED RISK FOR DECOMPENSATED HEART FAILURE AND CARDIOVASCULAR MORTALITY AMONG PERSONS LIVING WITH HIV. |
|---|---|
| Authors: | Alvi, Raza M.1, Neilan, Anne M.1, Tariq, Noor1, Awadalla, Magid1, Banerji, Dahlia1, Rokicki, Adam1, Triant, Virginia1, Zanni, Markella V.1, Neilan, Tomas1 |
| Source: | Journal of the American College of Cardiology (JACC). Mar2018 Supplement, Vol. 71, pA883-A883. 1p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
